IBDEI2M1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41684,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,41684,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,41685,0)
 ;;=Z98.61^^155^2062^20
 ;;^UTILITY(U,$J,358.3,41685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41685,1,3,0)
 ;;=3^Coronary angioplasty status
 ;;^UTILITY(U,$J,358.3,41685,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,41685,2)
 ;;=^5063742
 ;;^UTILITY(U,$J,358.3,41686,0)
 ;;=I42.0^^155^2062^22
 ;;^UTILITY(U,$J,358.3,41686,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41686,1,3,0)
 ;;=3^Dilated cardiomyopathy
 ;;^UTILITY(U,$J,358.3,41686,1,4,0)
 ;;=4^I42.0
 ;;^UTILITY(U,$J,358.3,41686,2)
 ;;=^5007194
 ;;^UTILITY(U,$J,358.3,41687,0)
 ;;=J43.9^^155^2062^23
 ;;^UTILITY(U,$J,358.3,41687,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41687,1,3,0)
 ;;=3^Emphysema, unspecified
 ;;^UTILITY(U,$J,358.3,41687,1,4,0)
 ;;=4^J43.9
 ;;^UTILITY(U,$J,358.3,41687,2)
 ;;=^5008238
 ;;^UTILITY(U,$J,358.3,41688,0)
 ;;=Z82.49^^155^2062^24
 ;;^UTILITY(U,$J,358.3,41688,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41688,1,3,0)
 ;;=3^Family hx of ischem heart dis and oth dis of the circ sys
 ;;^UTILITY(U,$J,358.3,41688,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,41688,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,41689,0)
 ;;=I50.9^^155^2062^25
 ;;^UTILITY(U,$J,358.3,41689,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41689,1,3,0)
 ;;=3^Heart failure, unspecified
 ;;^UTILITY(U,$J,358.3,41689,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,41689,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,41690,0)
 ;;=I25.2^^155^2062^27
 ;;^UTILITY(U,$J,358.3,41690,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41690,1,3,0)
 ;;=3^Old myocardial infarction
 ;;^UTILITY(U,$J,358.3,41690,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,41690,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,41691,0)
 ;;=I42.8^^155^2062^12
 ;;^UTILITY(U,$J,358.3,41691,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41691,1,3,0)
 ;;=3^Cardiomyopathies NEC
 ;;^UTILITY(U,$J,358.3,41691,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,41691,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,41692,0)
 ;;=I42.2^^155^2062^26
 ;;^UTILITY(U,$J,358.3,41692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41692,1,3,0)
 ;;=3^Hypertrophic cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,41692,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,41692,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,41693,0)
 ;;=I42.5^^155^2062^32
 ;;^UTILITY(U,$J,358.3,41693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41693,1,3,0)
 ;;=3^Restrictive cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,41693,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,41693,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,41694,0)
 ;;=Z95.1^^155^2062^29
 ;;^UTILITY(U,$J,358.3,41694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41694,1,3,0)
 ;;=3^Presence of aortocoronary bypass graft
 ;;^UTILITY(U,$J,358.3,41694,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,41694,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,41695,0)
 ;;=Z95.0^^155^2062^30
 ;;^UTILITY(U,$J,358.3,41695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41695,1,3,0)
 ;;=3^Presence of cardiac pacemaker
 ;;^UTILITY(U,$J,358.3,41695,1,4,0)
 ;;=4^Z95.0
 ;;^UTILITY(U,$J,358.3,41695,2)
 ;;=^5063668
 ;;^UTILITY(U,$J,358.3,41696,0)
 ;;=Z95.5^^155^2062^31
 ;;^UTILITY(U,$J,358.3,41696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41696,1,3,0)
 ;;=3^Presence of coronary angioplasty implant and graft
 ;;^UTILITY(U,$J,358.3,41696,1,4,0)
 ;;=4^Z95.5
 ;;^UTILITY(U,$J,358.3,41696,2)
 ;;=^5063673
